Advertisement

Topics

Marcum Cronus Partners Company Profile

06:58 EST 20th February 2018 | BioPortfolio

Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Marcum Cronus Partners is an investment banking firm that provides financial advisory and other investment banking services. The clients of the firm are publicly traded or privately owned companies that engage in middle-market transactions domestically or internationally. Winner of the Association for Corporate Growth’s 2012 Boutique Investment Bank of the Year Award, Marcum Cronus is an affiliate of Marcum LLP, one of the largest independent public accounting and advisory services firms in the U.S. (with 23 offices and more than 1,100 professionals). To learn more, please visit www.MarcumCronus.com.


News Articles [163 Associated News Articles listed on BioPortfolio]

Evariant Named Recipient of Marcum Tech Top 40 Award as one of Connecticut’s Fastest Growing Tech Companies

The Connecticut Technology Council (CTC) and Marcum LLP announced Evariant, the leading healthcare CRM data analytics platform, has made the Marcum Tech Top 40 (TT40) list of fast...

Partners Healthcare Closed $171M Innovation Fund for Life Sciences Startups

Partners HealthCare System has closed a $171 million innovation fund to invest in early stage life sciences startups. The innovation fund includes $66.1 million in outside capital for Partners Innovat...

Steward Partners and Raymond James Add Wells Fargo Advisors with over $230 Million to ...

"We are thrilled to welcome our newest partners from Wells Fargo this past week," said Hy Saporta, Steward Partners' president. "We continue to see interest Read more...

SunCoke Energy Partners, L.P. Announces Fourth Quarter 2017 Earnings Date

ABOUT SUNCOKE ENERGY PARTNERS, L.P. SunCoke Energy Partners, L.P. (NYSE: SXCP) is a publicly traded master limited partnership that manufactures high-quality coke used in Read more...

Molecular Partners AG: Molecular Partners' Collaboration Partner Allergan Exercises the Third Option for a DARPin(R) Product Candidate in Ophthalmology

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / February 19, 2018 / Molecular Partners AG (SWX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® thera.....

Partners HealthCare raises $171M for second innovation fund for healthcare startups (Updated)

Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.

MorphoSys-Aktie: Shortseller AHL Partners attackiert weiterhin! Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in MorphoSys-Aktien stark auf: Die Leerverkäufer von AHL Partners LLP attackieren die Aktien des Biotech-Unternehmens ....

MorphoSys-Aktie: Shortseller AHL Partners zieht sich weiterhin zurück - Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP baut Netto-Leerverkaufsposition in MorphoSys-Aktien signifikant ab: Die Leerverkäufer von AHL Partners LLP haben sich aus ihrem Short-Engagement in den ....

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [238 Associated PubMed Articles listed on BioPortfolio]

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

The Hidden Roles That Management Partners Play In Accountable Care Organizations.

Accountable care organizations (ACOs) are often discussed and promoted as driven by physicians, hospitals, and other health care providers. However, because of the flexible nature of ACO contracts, ma...

Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.

Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, dep...

A Qualitative Study of Means to Improve Partner Notification After an HIV Diagnosis Among Men Who Have Sex with Men in Australia.

Improved partner notification (PN) after HIV diagnosis could help control HIV among men who have sex with men (MSM). However, there is little evidence exploring what this experience is like for Austra...

Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy.

The diagnosis and treatment of prostate cancer adversely affects the physical and emotional well-being of patients and partners and has been associated with sexual dysfunction in patients and their in...

Clinical Trials [270 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

The objective this study is evaluate the performance and safety of Chronus® cobalt-chromium coronary stent in patients with "de novo" native coronary artery lesions treated with 19-mm-lon...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [900 Associated Companies listed on BioPortfolio]

Marcum Cronus Partners

Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Marcum Cronus Partners is an investment banking firm that provides financial advisory and...

SageCreek Partners

SageCreek Partners is creating and driving a new category of service: Mentor Capital. Working as a companion to technology companies and their investment partners and boards, Sage...

Health Partners Plans (HPP)

Nationally recognized for its innovations in managed care, Health Partners Plans consistently receives the highest ratings for member and provider satisfaction and, is currently r...

Prospect Partners, LLC

Prospect Partners is a leading private equity firm investing in smaller lower-middle-market companies, managing $470 million across three funds. A highly experienced and active in...

Vista Partners

With offices in California and Oregon, Vista Partners LLC is one of the fastest growing independently owned equity research and consulting firms in the United States. Vista Partners professional staff...

More Information about "Marcum Cronus Partners" on BioPortfolio

We have published hundreds of Marcum Cronus Partners news stories on BioPortfolio along with dozens of Marcum Cronus Partners Clinical Trials and PubMed Articles about Marcum Cronus Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marcum Cronus Partners Companies in our database. You can also find out about relevant Marcum Cronus Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record